Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest chemotherapy Stories

2014-04-08 12:31:44

Metronomic algorithms for targeted therapy to improve value of response and "failed drugs" for "resistant women's cancers" NEW YORK, April 8, 2014 /PRNewswire/ -- The following will be presented this week at the annual meeting of the American Association of Cancer Research, San Diego. Dr Howard Bruckner will present accumulating evidence describing a novel successful treatment for patients with resistant ovarian cancer. Low dose chemotherapy as cores, selected drug combinations,...

2014-04-08 08:31:39

OICR's catalyst grant enables WaveCheck to open first partner site at MD Anderson Cancer Center in May TORONTO, April 8, 2014 /PRNewswire/ - People with breast cancer are a step closer to knowing if their tumour is responding to chemotherapy at the start of treatment, thanks to a $100,000 catalyst grant from the Ontario Institute for Cancer Research (OICR). The funding builds upon MaRS Innovation's Indiegogo crowdfunding campaign for WaveCheck, which successfully raised over...

2014-04-08 08:30:19

SAN DIEGO, April 8, 2014 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation. "Initiation of...

2014-04-07 16:25:44

Largest-ever gift to the Hutch promises to save lives by broadening the application of immunotherapy to lung, ovarian, pancreatic and colon cancers SEATTLE, April 7, 2014 /PRNewswire/ -- Fred Hutchinson Cancer Research Center scientists striving for new cancer cures -- and the patients who stand to benefit from them -- got an enormous boost today when the Bezos family committed $20 million to support the development of novel cancer immunotherapies. It is the largest single...

2014-04-07 12:33:26

New data demonstrates VAL-083 is superior to standard platinum-based chemotherapy in an established in vivo model of non-small cell lung cancer (NSCLC) VANCOUVER, British Columbia, MENLO PARK, Calif. and SAN DIEGO, April 7, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the presentation of new data in a poster entitled, "In vivo efficacy of VAL-083 in the treatment of non-small cell lung cancer." DelMar's data was presented on Sunday, April 6, 2014...

2014-04-07 08:30:00

Phase I Demonstrates Quizartinib Tolerability in Combination with Chemotherapy SAN DIEGO, April 7, 2014 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the Phase 2 cohort of the MD Anderson Cancer Center-sponsored Phase 1/2 study of quizartinib in combination with either 5-azacitidine or low dose...

2014-04-07 08:29:57

PRINCETON, N.J., April 7, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Dental and Craniofacial Research (NIDCR) has awarded Soligenix a Small Business Innovation Research (SBIR) grant...

2014-04-03 08:30:43

ALBANY, New York, April 3, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Infusion Pumps Market (Large Volume, Disposable, Syringe, Ambulatory and Implantable) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global infusion pumps market was valued at USD 5.4 billion in 2012 and is expected to grow at a CAGR of 5.3% from 2013 to 2019, to reach an estimated value of USD 7.8 billion in...

2014-04-02 20:21:41

Upper Deck plans to create a series of trading cards around other inspirational youngsters in the Friends of Jaclyn organization, with their motivational leader receiving the first card! CARLSBAD, Calif., April 2, 2014 /PRNewswire/ -- Jaclyn Murphy has been profiled on HBO's "Real Sports" twice and her inspirational story leaves everyone who has seen those shows deeply affected. She grew up with a love for the sport of lacrosse, but at just 9-years-old doctors discovered she had a...

2014-04-01 12:31:21

Surgery for "operable" tumor is also possible but may not be necessary NEW YORK, April 1, 2014 /PRNewswire-USNewswire/ -- Hall of Fame quarterback Jim Kelly will start chemotherapy and radiation treatments targeting cancer cells in his maxillary sinus and adjacent tissues next week, Peter D. Costantino, MD, executive director of Lenox Hill Hospital's New York Head & Neck Institute, reported today. Mr. Kelly will be receiving a single dose of chemotherapy at Lenox Hill Hospital,...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »